Publications
Sort:
Clinical Research Issue
Predictive effect of remimazolam on organ function in elderly patients undergoing cardiac valve replacement
Chinese Journal of Multiple Organ Diseases in the Elderly 2026, 25(6): 458-463
Published: 28 June 2026
Abstract PDF (439.9 KB) Collect
Downloads:0
Objective

To investigate the effect of remimazolam in elderly patients undergoing cardiac replacement and its protective effect on organ function.

Methods

Prospectively, a total of 130 elderly patients undergoing elective cardiac valve replacement admitted to Yuncheng Central Hospital from January 2023 to January 2025 were enrolled as study subjects. The patients were divided into a study group (using remimazolam for anesthesia induction and maintenance) and control group (using propofol for anesthesia induction and maintenance) by a random number table method, with 65 cases in each group. Hemodynamic parameters [mean arterial pressure (MAP) and heart rate (HR)] were recorded in the two groups before anesthesia induction (T0), during intubation (T1), during skin incision (T2), and during sternal sawing (T3). Peripheral venous blood was collected before surgery and at day 3 after surgery to assess liver and kidney function and myocardial injury markers. The intraoperative and postoperative anesthesia-related adverse reactions and intraoperative sedation effectiveness were recorded. SPSS 27.0 was used for data processing. According to the data type, independent sample t test, χ2, Fisher′s exact test, or continuity-corrected Chi-square test, was performed for intergroup comparisons, and paired t test was used for intragroup comparisons.

Results

MAP values in the study group at T0-T3 were (94.15±6.48), (88.15±7.73), (79.36±7.46), and (80.33±8.04) mmHg (1mmHg=0.133kPa), respectively; in the control group, they were (95.03±8.11), (77.54±7.91), (74.39±7.49), and (76.98±7.15) mmHg, respectively. HR values in the study group at T0-T3 were (80.39±7.25), (81.39±6.98), (69.43±7.29), and (75.82±7.33) beats/min, respectively; in the control group, they were (81.05±8.83), (74.17±7.49), (64.35±6.87), and (68.04±7.04) beats/min, respectively. MAP and HR fluctuations at different perioperative time points were statistically significant in both groups (P<0.05), MAP and HR levels in the study group were significantly higher than those in the control group at T1, T2, and T3 (P<0.05). Compared with preoperative levels, levels of blood urea nitrogen, aspartate aminotransferase (AST), N-terminal pro-B-type natriuretic peptide, cardiac troponin I (CTnI), and creatine kinase isoenzyme-MB increased in both groups at day 3 after surgery (P<0.05). In control group, serum creatinine (SCr) at day 3 after surgery was significantly higher and estimated glomerular filtration rate (eGFR) was significantly lower than those before surgery (P<0.05) . No significant changes in SCr and eGFR were observed in the study group before and after surgery (P>0.05). SCr, AST, and CTnI levels in the study group were significantly lower than those in the control group at day 3 after surgery, with statistically significant differences (P<0.05). The incidence rates of intraoperative hypotension and injection pain were lower in study group than those in control group (P<0.05). There were no statistical differences in the proportions of remedial cases during induction and maintenance or in sedation success rate between the two groups in intraoperative (P>0.05).

Conclusion

Remimazolam has a good sedation effect in elderly patients undergoing valve replacement and is valuable in reducing perioperative hemodynamic fluctuations, protecting organ functions and reducing intraoperative adverse reactions.

Total 1